Zentek Ltd. ZTEKF

Zentek Ltd. filed an independent technical report for its Albany graphite project in Northern Ontario, confirming the economics outlined in an earlier preliminary economic assessment. The study shows an after-tax NPV of about US$3.85 billion at a 5% discount, an after-tax IRR of 27.4%, and a payback of 4.4 years, with estimated initial capex of roughly US$870 million. Albany is planned as a 30-year mine delivering about 30,000 tonnes per year of ultra-high-purity graphite products, priced on an average US$23,480/tonne, reflecting emphasis on specialty markets rather than commodity graphite. The project uses Zentek's acid-free fluidized bed reactor purification, achieving bench-scale purities of 99.99985% carbon and four grades from 4N to 5N. Plans for a pre-feasibility study focus on resource definition, mine design, purification testing, scale-up, infrastructure, and environmental baselines, with engagement ongoing with Constance Lake First Nation. Multi-billion NPV and strong IRR create substantial potential for Zentek's development trajectory, signaling meaningful long-term impact despite ongoing next steps.

Zentek filed a NI 43-101 Preliminary Economic Assessment for the Albany Graphite Project, with independent reviewer Micon International. After-tax NPV at 5% is US$3.8545 billion and after-tax IRR 27.4%, based on US$817.0 million initial capex and a 30-year production window within a 35-year project life. The plan targets about 30,000 tonnes per year of finished ultra-high-purity graphite produced from 34,483 t/yr flotation concentrate, using an acid- and halogen-free thermal purification process (fluidized bed reactor). A long-run product price of US$23,485/tonne and a 3.9% Cg head grade underpin the economics. Sustaining capital US$1,161.6 million and LOM operating costs US$6,666.2 million yield a discounted payback of 4.4 years. Micon recommends advancing Albany to a Pre-Feasibility Study; the Technical Report is dated June 30, 2026 and filed September 24, 2026. Robust after-tax economics (NPV US$3.85B, IRR 27.4%) and a recommendation to proceed to Pre-Feasibility signal potentially material value creation.

Zentek Ltd. pre-qualifies under Canada's Defence Drone Initiative Marketplace, positioning the company for potential defense-related drone opportunities. Pre-qualification opens access to government defense contracts that may generate new revenue.

Zentek Ltd. provides corporate update on its operations and developments. Corporate updates can include strategic or operational details with moderate effects on performance and sentiment.

Zentek Ltd. provides an update on its Nasdaq listing. Nasdaq listing update represents a major step that could enhance market access and investor interest for Zentek Ltd.

Zentek Ltd. (ZTEK) has been awarded a Canadian government standing offer contract to supply HVAC filters. Standing offer contract creates potential sales channel and market credibility for HVAC products without guaranteed large-scale revenue.

Zentek Ltd. receives Government of Canada Standing Offer for HVAC Filters. Standing offer creates potential revenue channel via government HVAC filter supply without guaranteed large-scale immediate sales.

Zentek Ltd. files provisional patent application for absorption-based EMI shielding coating made from Albany Graphite. Provisional patent on new EMI coating technology signals moderate innovation potential for Zentek without immediate commercial impact.

Zentek Ltd. reported a new Preliminary Economic Assessment for the Albany Graphite project with an after-tax NPV of US$3.85 billion at a 5% discount rate, 27.4% after-tax IRR, and an acid-free method producing 99.9992% purity graphite. Strong PEA results position the Albany Graphite project as a high-value asset with substantial economic returns and advanced purification capabilities.

Zentek's ZenGUARD Enhanced Air Filtration Media completed qualification program with Quality Filters Inc. and received first U.S. commercial order. Qualification and first U.S. order enable market expansion and revenue growth for Zentek.

Zentek Ltd. has established a pathway to sell ZenGUARD enhanced air filtration media in the U.S. Pathway to U.S. sales for ZenGUARD media positions Zentek for expanded market reach and revenue growth.

Zentek Ltd. forms U.S. joint venture to integrate Albany ultra-high-purity graphite into North American national-security supply chain. U.S. joint venture directly targets national-security supply chain for Albany graphite, indicating major strategic expansion.

Zentek Ltd. receives U.S. patent for ZenGUARD graphene-based technology. U.S. patent grant for core ZenGUARD technology strengthens IP protection and supports competitive positioning.

Zentek Ltd. closed a fully subscribed brokered LIFE offering, securing C$18 million in gross proceeds. C$18 million equity raise strengthens balance sheet and funds operations without altering core trajectory.

Zentek Ltd. announces its brokered LIFE offering has been oversubscribed and fully allocated. Oversubscribed offering secures extra capital for Zentek while signaling strong investor demand that supports near-term financial flexibility and share sentiment.

Zentek Ltd. (ZTEK) announces a brokered LIFE offering for gross proceeds of up to C$15 million. Raising up to C$15 million via brokered LIFE offering provides substantial capital for Zentek's operations and growth, likely driving significant positive impact on future performance and investor sentiment.

Zentek Ltd.'s ZenGUARD™ enhanced air filters are now available for direct procurement by all U.S. federal departments and agencies via the GSA Advantage platform, expanding access to government buyers. Direct procurement approval by all federal agencies unlocks vast government contract opportunities, boosting revenue potential and market positioning.

Zentek Ltd. (ZTEK) is now accepting commercial orders in Canada for ZenGUARD enhanced air filters after Health Canada issued a favorable regulatory classification. Health Canada classification unlocks commercial sales of ZenGUARD filters, enabling revenue generation and market expansion.

Albany Graphite, a Zentek Ltd. subsidiary, launches year two of its Environmental and Social Baseline Program in partnership with ERM and Constance Lake First Nation to support the Albany Graphite Project's development. Advancing year two environmental and social baseline program with key partners aids permitting and ESG compliance for Zentek's graphite project.

Albany Graphite executed an agreement with AETC for certified samples and process engineering, completing the set of three independent workstreams feeding into the Preliminary Economic Assessment (PEA). Finalizing the three workstreams advances Zentek's Albany Graphite project to PEA completion, a major milestone boosting project viability and investor sentiment.

Triera Biosciences completes Innovative Solutions Canada contract, advancing its therapeutic platform toward new candidate development as a Zentek Ltd. initiative. Contract completion and platform advancement bolster Zentek's biotech pipeline and innovation efforts.

Albany Graphite Corp. engages Micon International to complete a new Preliminary Economic Assessment for the Albany Graphite Project. Commissioning a new PEA advances Zentek's key graphite project toward improved economics and stronger market positioning.

Triera Biosciences, a Zentek Ltd. company, launches contract research organization services for custom aptamer discovery, biosensor enablement, and machine-learning classification. Launching specialized CRO services diversifies Zentek's revenue into biotech R&D, enhancing growth potential and competitive positioning.

Zentek Ltd. (ZTEK) has received a favorable judgment in its long-standing litigation, resolving a key legal dispute. Favorable judgment eliminates long-standing legal uncertainty, likely improving financial position and investor sentiment significantly.

Zentek Ltd. (ZTEK) outlines government engagement strategy and announces plans to advance Albany Graphite project toward new Preliminary Economic Assessment. Advancing Albany Graphite to new PEA and government engagement strategy represent major strategic moves enhancing project viability and investor appeal.

Zentek Ltd. announced strategic updates including Health Canada's ongoing review of ZenGUARD N95 respirator submission with decision expected Q4 2024, new U.S. patent allowance for graphene-based antimicrobials, progress on HVAC filter partnerships, and plans for ZenGUARD commercialization. Regulatory progress on ZenGUARD N95 and new patents represent major steps toward product commercialization, potentially transforming revenue prospects and competitive edge.

Zentek Ltd. has issued a shareholder letter detailing a strategic reset and a focused growth plan aimed at enhancing operational efficiency and market positioning. The company is prioritizing key areas for development and innovation, signaling a commitment to long-term growth and shareholder value. This strategic shift is expected to streamline operations and align resources more effectively with market demands. The strategic reset and focused growth plan are likely to significantly impact the company's future performance and investor sentiment.

Zentek Ltd. has announced that its Albany graphite has achieved nuclear-grade performance in independent testing. This significant milestone opens up opportunities for the company to enter various high-return commercial markets, potentially enhancing its market position and revenue streams. Achieving nuclear-grade performance positions Zentek to significantly impact its market trajectory and investor sentiment.

Zentek Ltd. (ZTEK) is highlighted as one of three promising penny stocks on the TSX with a market cap under CA$200 million. The company focuses on advanced materials and technologies, particularly in the field of graphene. Its innovative solutions have potential applications in various industries, including healthcare and energy. Investors are encouraged to consider ZTEK for its growth prospects and strategic positioning in emerging markets. Zentek's focus on advanced materials and potential applications in multiple industries may moderately influence its market performance.

Zentek Ltd.'s subsidiary, Albany Graphite Corp., has achieved near-theoretical performance for anode materials in independent battery testing. This milestone indicates significant advancements in the suitability of Albany's graphite for battery applications, potentially enhancing the company's position in the energy storage market. The results suggest that Albany's graphite could play a crucial role in the development of high-performance batteries, aligning with growing demand for efficient energy solutions. Achieving near-theoretical anode performance could significantly enhance product offerings and market competitiveness.